ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 38 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 42.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $798 | -20.2% | 2,217 | +38.6% | 0.00% | – |
| Q3 2022 | $1,000 | -83.3% | 1,600 | -74.9% | 0.00% | – |
| Q1 2022 | $6,000 | -71.4% | 6,369 | -46.0% | 0.00% | – |
| Q3 2021 | $21,000 | +50.0% | 11,793 | +176.6% | 0.00% | – |
| Q2 2021 | $14,000 | +600.0% | 4,264 | +616.6% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 595 | -52.2% | 0.00% | – |
| Q4 2020 | $2,000 | -33.3% | 1,246 | -16.8% | 0.00% | – |
| Q2 2020 | $3,000 | -25.0% | 1,498 | -62.4% | 0.00% | – |
| Q1 2020 | $4,000 | – | 3,984 | +2556.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 150 | -96.3% | 0.00% | – |
| Q3 2019 | $7,000 | -22.2% | 4,077 | +39.8% | 0.00% | – |
| Q2 2019 | $9,000 | -35.7% | 2,917 | -13.5% | 0.00% | – |
| Q1 2019 | $14,000 | 0.0% | 3,374 | -10.4% | 0.00% | – |
| Q4 2018 | $14,000 | – | 3,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,270,758 | $2,262,000 | 0.72% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $4,476,000 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 975,305 | $1,736,000 | 0.36% |
| DAFNA Capital Management LLC | 732,500 | $1,304,000 | 0.35% |
| KNOTT DAVID M | 478,186 | $851,000 | 0.31% |
| Vivo Capital, LLC | 2,840,909 | $5,057,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 688,400 | $1,225,000 | 0.17% |
| MYDA Advisors LLC | 236,165 | $420,000 | 0.12% |
| Affinity Asset Advisors, LLC | 250,000 | $445,000 | 0.11% |
| RTW INVESTMENTS, LP | 3,250,000 | $5,785,000 | 0.09% |